Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Maryland, Baltimore
Dana-Farber Cancer Institute
Massachusetts General Hospital
University of California, San Francisco
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins